Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Translational Research

Background:

• Valvular calcification, affecting mitral and aortic valves, is highly prevalent in chronic kidney disease (CKD) patients.
• This condition significantly correlates with increased cardiovascular and all-cause mortality risk in CKD individuals.
• Current understanding of the exact mechanisms driving heart valve calcification in CKD remains incomplete, and existing treatments lack efficacy in preventing valvular fibrocalcific remodeling.

Purpose of the Study:

• To summarize current knowledge on mechanisms linking CKD and its therapies to valvular cell activity.
• To present novel therapeutic targets identified through preclinical studies for valvular calcification.
• To discuss recent clinical trials assessing therapies for preventing valvular calcification in CKD.

Main Methods:

• Literature review of preclinical studies on CKD-related valvular calcification mechanisms.
• Analysis of identified therapeutic targets in experimental models.
• Review of recent clinical trial data on preventative therapies for valvular calcification in CKD.

Main Results:

• The review synthesizes existing data on how CKD impacts valvular cells.
• Several promising therapeutic targets have emerged from preclinical research.
• Clinical trials are exploring various strategies, but efficacy data is still being gathered.

Conclusions:

• A deeper understanding of CKD-associated valvular calcification mechanisms is essential for developing effective therapies.
• Targeting specific pathways identified in preclinical studies holds therapeutic potential.
• Ongoing clinical trials are critical for validating new treatments to prevent valvular calcification in CKD.